Placebo-controlled trial of prednisolone in children intubated for croup

J Tibballs1, F A Shann, L I Landau

  • 1Intensive Care Unit, Royal Children's Hospital, Melbourne, Australia.

Lancet (London, England)
|September 26, 1992
PubMed

Insights

Steroid treatment with prednisolone significantly reduces the need for reintubation and shortens the duration of intubation in children with croup. This finding offers a clear benefit for managing intubated pediatric patients with croup.

Area of Science:

  • Pediatric Critical Care
  • Respiratory Medicine
  • Pharmacology

Background:

  • Croup is a common pediatric respiratory illness.
  • The efficacy of steroid treatment in intubated children with croup remains debated.
  • Previous studies have yielded inconclusive results regarding steroid benefits.

Purpose of the Study:

  • To prospectively evaluate the effect of prednisolone on intubation duration and reintubation rates in children with croup.
  • To provide conclusive evidence on steroid therapy's role in managing intubated croup patients.

Main Methods:

  • A prospective, placebo-controlled study involving 70 eligible children.
  • Random assignment to receive either prednisolone (1 mg/kg) or placebo every 12 hours.
  • Primary endpoints were duration of intubation and need for reintubation.

Main Results:

  • Prednisolone significantly reduced reintubation rates (5% vs. 34%, p = 0.004).
  • Steroid therapy shortened the median intubation duration (98 hours vs. 138 hours).
  • Increasing age was also associated with shorter intubation duration.

Conclusions:

  • Prednisolone is effective in reducing the duration of intubation in children with croup.
  • Steroid administration decreases the likelihood of reintubation in this patient population.
  • This study provides strong evidence supporting the use of steroids for intubated children with croup.

Related Concept Videos

Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...